Abstract
Ankylosing spondylitis (AS) mainly affects axial joints, and is also a chronic inflammatory joint disorder with peripheral joint and systemic involvement. Its etiology is unclear, but the efficacy of salicylazosulfapyridine (SASP) in treating AS is generally acknowledged. There is also report on the pure Chinese medical preparation Zhengqing Fengtongning ( ZQFTN, t N N, Ni ~ ) in treating AS (1~ , but there are no reports on whether the ZQFTN and SASP combination therapy can increase the efficacy, or on their side-effects when combined. Since 1996 our hospital has used combination therapy in treating active AS, and compared this with those using SASP alone as control. The results are reported as follows.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Chinese Journal of Integrated Traditional and Western Medicine
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
